HBSAg Produkte
(Hepatitis B Virus Surface Antigen (HBsAg))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte HBSAg Kategorien
HBSAg Antikörper
High quality antibodies with extensive validation data.
HBSAg ELISA Kits
Reliable ELISA kits for a wide range of species.
HBSAg Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene HBSAg Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Hepatitis B Virus (HBV), Mouse, Rat, Virus
Applikation
ELISA
Validierungen
- (3)
Kat. Nr.
ABIN723066
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human, Mouse, Virus
Applikation
ELISA, WB, IF (cc), IF (p), IHC (p), IHC (fro)
Validierungen
- (11)
Kat. Nr.
ABIN731303
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human, Mouse, Virus
Applikation
ELISA, WB, IHC (p), IHC (fro)
Validierungen
- (1)
Kat. Nr.
ABIN731305
Menge
100 μL
Datenblatt
Datenblatt
Empfohlene HBSAg ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6962773
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Hepatitis B Virus (HBV)
Analytical Method
Qualitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN997015
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Qualitative
Validierungen
Kat. Nr.
ABIN5520812
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene HBSAg Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Hepatitis B Virus (HBV)
Source
CHO Cells
Validierungen
Kat. Nr.
ABIN7385310
Menge
1 mg
Datenblatt
Datenblatt
Reaktivität
Hepatitis B Virus (HBV)
Source
Human
Validierungen
Kat. Nr.
ABIN810012
Menge
1 mg
Datenblatt
Datenblatt
Reaktivität
Hepatitis B Virus (HBV)
Source
Human
Validierungen
Kat. Nr.
ABIN7385309
Menge
1 mg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren HBSAg Produkten
: "Evaluation of antiviral - passive - active immunization ("sandwich") therapeutic strategy for functional cure of chronic hepatitis B in mice." in: EBioMedicine, Vol. 49, pp. 247-257, (2020) (PubMed).: "Differences in HBV Replication, APOBEC3 Family Expression, and Inflammatory Cytokine Levels Between Wild-Type HBV and Pre-core (G1896A) or Basal Core Promoter (A1762T/G1764A) Mutants." in: Frontiers in microbiology, Vol. 11, pp. 1653, (2020) (PubMed).
: "Immunization with lentiviral vector‑modified dendritic cells encoding ubiquitinated hepatitis B core antigen promotes Th1 differentiation and antiviral immunity by enhancing p38 MAPK and JNK ..." in: Molecular medicine reports, Vol. 18, Issue 5, pp. 4691-4699, (2019) (PubMed).
: "Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway." in: Free radical biology & medicine, Vol. 131, pp. 225-236, (2019) (PubMed).
: "Vaccination with a DNA vaccine encoding CD317-targeting HBs antigen elicits enhanced immunity in mice." in: Biochemical and biophysical research communications, Vol. 504, Issue 4, pp. 865-870, (2019) (PubMed).
: "Zeaxanthin dipalmitate alleviates hepatic injury induced by superimposed chronic hepatitis B and non-alcoholic steatohepatitis in non-obese mice." in: Journal of Asian natural products research, Vol. 19, Issue 9, pp. 910-923, (2018) (PubMed).
: "Cisplatin Enhances Hepatitis B Virus Replication and PGC-1α Expression through Endoplasmic Reticulum Stress." in: Scientific reports, Vol. 8, Issue 1, pp. 3496, (2018) (PubMed).
: "The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients." in: Journal of the National Medical Association, Vol. 110, Issue 3, pp. 256-264, (2018) (PubMed).
: "Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO's elimination strategy." in: BMC public health, Vol. 17, Issue 1, pp. 636, (2018) (PubMed).
: "Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection." in: Scientific reports, Vol. 7, pp. 45698, (2017) (PubMed).
Sie sind hier:
